Goldan Keith A. 4
4 · Syndax Pharmaceuticals Inc · Filed Aug 7, 2025
Insider Transaction Report
Form 4
Goldan Keith A.
Chief Financial Officer
Transactions
- Other
Common Stock
2025-07-31$8.43/sh+1,226$10,335→ 93,676 total
Footnotes (1)
- [F1]The Reporting Person is voluntarily filing this Form 4 to report the acquisition of 1,226 shares by the Reporting Person on 07/31/2025 pursuant to the Issuer's Employee Stock Purchase Plan.